Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A METHYL AMINOLEVULINATE HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of METHYL AMINOLEVULINATE HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates METHYL AMINOLEVULINATE HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. METHYL AMINOLEVULINATE HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A METHYL AMINOLEVULINATE HYDROCHLORIDE supplier is an individual or a company that provides METHYL AMINOLEVULINATE HYDROCHLORIDE active pharmaceutical ingredient (API) or METHYL AMINOLEVULINATE HYDROCHLORIDE finished formulations upon request. The METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers may include METHYL AMINOLEVULINATE HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
click here to find a list of METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A METHYL AMINOLEVULINATE HYDROCHLORIDE CEP of the European Pharmacopoeia monograph is often referred to as a METHYL AMINOLEVULINATE HYDROCHLORIDE Certificate of Suitability (COS). The purpose of a METHYL AMINOLEVULINATE HYDROCHLORIDE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of METHYL AMINOLEVULINATE HYDROCHLORIDE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of METHYL AMINOLEVULINATE HYDROCHLORIDE to their clients by showing that a METHYL AMINOLEVULINATE HYDROCHLORIDE CEP has been issued for it. The manufacturer submits a METHYL AMINOLEVULINATE HYDROCHLORIDE CEP (COS) as part of the market authorization procedure, and it takes on the role of a METHYL AMINOLEVULINATE HYDROCHLORIDE CEP holder for the record. Additionally, the data presented in the METHYL AMINOLEVULINATE HYDROCHLORIDE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the METHYL AMINOLEVULINATE HYDROCHLORIDE DMF.
A METHYL AMINOLEVULINATE HYDROCHLORIDE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. METHYL AMINOLEVULINATE HYDROCHLORIDE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing METHYL AMINOLEVULINATE HYDROCHLORIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for METHYL AMINOLEVULINATE HYDROCHLORIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture METHYL AMINOLEVULINATE HYDROCHLORIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain METHYL AMINOLEVULINATE HYDROCHLORIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a METHYL AMINOLEVULINATE HYDROCHLORIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers with NDC on PharmaCompass.
METHYL AMINOLEVULINATE HYDROCHLORIDE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of METHYL AMINOLEVULINATE HYDROCHLORIDE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right METHYL AMINOLEVULINATE HYDROCHLORIDE GMP manufacturer or METHYL AMINOLEVULINATE HYDROCHLORIDE GMP API supplier for your needs.
A METHYL AMINOLEVULINATE HYDROCHLORIDE CoA (Certificate of Analysis) is a formal document that attests to METHYL AMINOLEVULINATE HYDROCHLORIDE's compliance with METHYL AMINOLEVULINATE HYDROCHLORIDE specifications and serves as a tool for batch-level quality control.
METHYL AMINOLEVULINATE HYDROCHLORIDE CoA mostly includes findings from lab analyses of a specific batch. For each METHYL AMINOLEVULINATE HYDROCHLORIDE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
METHYL AMINOLEVULINATE HYDROCHLORIDE may be tested according to a variety of international standards, such as European Pharmacopoeia (METHYL AMINOLEVULINATE HYDROCHLORIDE EP), METHYL AMINOLEVULINATE HYDROCHLORIDE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (METHYL AMINOLEVULINATE HYDROCHLORIDE USP).
LOOKING FOR A SUPPLIER?
